Center for Innovative NeuroTech Advancement – Administrative Core
Official title: Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
Funded at Massachusetts General Hospital · NIH-11602008 · Data updated 2026-11-12
A patient-focused hub at a major hospital coordinates leadership and policy to speed brain-technology research into real healthcare use.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 30, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,473,250 |
| NIH project number | 3U54EB033650-05S8 |
| Project ID | NIH-11602008 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with neurological conditions and caregivers who can contribute perspectives and participate in future translational efforts.
✕Less likely to help
This administrative grant does not directly enroll patients or provide immediate therapies.
What this research studies
This grant supports an Administrative Core that leads and manages a national brain-technology hub. It emphasizes governance, policy development, and ongoing improvement based on real-time metrics and stakeholder input, including patient communities. The aim is to accelerate translation of neurotechnology ideas into clinically useful tools and therapies. Patients and advocacy groups are intended to help shape decisions and priorities through steering and leadership activities.
Why it matters
Potential benefit: If successful, this core could streamline development of brain technologies that improve diagnosis, monitoring, and treatment for neurological conditions.
How similar studies have gone: Past administrative cores have effectively sped up translational pathways by coordinating multiple centers and stakeholders.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Schachter, Steven C. — Massachusetts General Hospital
- Study coordinator: Schachter, Steven C.
Related research
Other NIH-funded projects on the same topics.
-
Global TravEpiNet: Pregnant Travelers Health and Disease Prevention Network
This grant supports a national network to improve health and prevent infections among international travelers, with a special focus on pregnant travelers.
-
Soluble ST2 and the course of lung injury in ARDS
A doctor-scientist at a top hospital is studying how a molecule called soluble ST2 may influence how lung injury starts and heals in patients with ARDS and related conditions.
-
Role of airway macrophages in lung health and allergic disease
A doctor-scientist at a major hospital wants to study how immune cells in the airways develop and influence asthma and other airway diseases.
-
Global TravEpiNet: Understanding and Protecting US Travelers, including Pregnant Travelers
A large U.S. network studies international travelers, including pregnant travelers, to understand illness risks and reduce the spread of infections.
-
Gait speed from wearable sensors to guide ALS trials
A patient-friendly look at using wearable sensors to measure how fast people with ALS walk, to help run better ALS trials.
-
Determinants of Post-Stroke Cognitive Outcomes and Vascular Effects on Recovery
A large, multi-site effort aims to understand why some stroke survivors develop long-term cognitive problems and dementia, and how vascular health and pre-existing brain changes influence recovery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.